Skip to Content

USL 070 (Potassium Citrate Extended-Release 5 mEq (540 mg))

Pill with imprint USL 070 is Tan, Round and has been identified as Potassium Citrate Extended-Release 5 mEq (540 mg). It is supplied by Upsher-Smith Laboratories, Inc.

Potassium citrate is used in the treatment of renal tubular acidosis; nephrolithiasis and belongs to the drug class urinary pH modifiers. Risk cannot be ruled out during pregnancy. Potassium citrate 5 mEq (540 mg) is not a controlled substance under the Controlled Substances Act (CSA).

Images for USL 070

Potassium citrate extended-release 5 mEq (540 mg) USL 070
Potassium citrate extended-release 5 mEq (540 mg) USL 070
Potassium citrate extended-release 5 mEq (540 mg) USL 070 Front
Potassium citrate extended-release 5 mEq (540 mg) USL 070 Back
Potassium citrate extended-release 5 mEq (540 mg) USL 070

Potassium Citrate Extended-Release

Imprint
USL 070
Strength
5 mEq (540 mg)
Color
Tan
Size
10.00 mm
Shape
Round
Availability
Prescription only
Drug Class
Urinary pH modifiers
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Upsher-Smith Laboratories, Inc
National Drug Code (NDC)
00245-0070
Inactive Ingredients
carnauba wax, magnesium stearate

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.